NCT00163852View on ClinicalTrials.gov

Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

February 28, 2006

Conditions
Cystic Fibrosis
Interventions
DRUG

Normal saline IV, salt tablets

Trial Locations (1)

3181

RECRUITING

The Alfred, Melbourne

Sponsors

Lead Sponsor

Bayside Health
All Listed Sponsors
collaborator

National Health and Medical Research Council, Australia

OTHER

collaborator

Monash University

OTHER

collaborator

Cystic Fibrosis Federation Australia

OTHER

lead

Bayside Health

OTHER_GOV

NCT00163852 - Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis | Biotech Hunter | Biotech Hunter